|
PARP16 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.71099999999714E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.421400E-03 |
| Normal-vs-Stage2 |
3.139600E-02 |
| Normal-vs-Stage3 |
3.580400E-01 |
| Normal-vs-Stage4 |
1.889840E-01 |
| Stage1-vs-Stage2 |
1.774830E-01 |
| Stage1-vs-Stage3 |
6.973400E-01 |
| Stage1-vs-Stage4 |
6.829600E-01 |
| Stage2-vs-Stage3 |
2.194000E-01 |
| Stage2-vs-Stage4 |
6.350000E-01 |
| Stage3-vs-Stage4 |
5.841600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.190200E-04 |
| Normal-vs-AfricanAmerican |
2.521300E-03 |
| Normal-vs-Asian |
1.264620E-01 |
| Caucasian-vs-AfricanAmerican |
2.715800E-01 |
| Caucasian-vs-Asian |
8.386000E-01 |
| AfricanAmerican-vs-Asian |
2.893800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.237900E-03 |
| Normal-vs-Female |
1.92812999999514E-05 |
| Male-vs-Female |
4.636600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.924700E-03 |
| Normal-vs-Extreme_Weight |
9.880200E-02 |
| Normal-vs-Obese |
1.819810E-02 |
| Normal-vs-Extreme_Obese |
8.811800E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.057850E-01 |
| Normal_Weight-vs-Obese |
3.825200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.817600E-01 |
| Extreme_Weight-vs-Obese |
3.330800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.065400E-01 |
| Obese-vs-Extreme_Obese |
8.038800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.402600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.87319999994862E-06 |
| Normal-vs-Age(61-80Yrs) |
2.656100E-02 |
| Normal-vs-Age(81-100Yrs) |
4.149200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.069200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.491600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.746400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.729900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.920600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.724200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.150740E-04 |
| Normal-VS-Type2 PRCC |
2.595800E-02 |
| Normal-VS-KIRP CIMP |
4.088400E-02 |
| Normal-VS-Unclassified PRCC |
1.695960E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.866200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.462600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.478800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.566400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.372200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.884300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.589700E-02 |
| Normal-vs-N1 |
7.045800E-01 |
| Normal-vs-N2 |
5.808600E-01 |
| N0-vs-N1 |
4.441400E-01 |
| N0-vs-N2 |
3.885200E-01 |
| N1-vs-N2 |
7.387800E-01 |
|
|
